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Background: More than 70 % of the cases of congenital deafness are of genetic origin, of which approximately
80 % are non-syndromic and show autosomal recessive transmission (DFNB forms). To date, 60 DFNB genes have
been identified, most of which cause congenital, severe to profound deafness, whereas a few cause delayed
progressive deafness in childhood. We report the study of two Algerian siblings born to consanguineous parents,
and affected by progressive hearing loss.
Method: After exclusion of GJB2 (the gene most frequently involved in non-syndromic deafness in Mediterranean
countries), we performed whole-exome sequencing in one sibling.
Results: A frame-shift variant (c.1014delC; p.Ser339Alafs*15) was identified in EPS8L2, encoding Epidermal growth
factor receptor Pathway Substrate 8 L2, a protein of hair cells’ stereocilia previously implicated in progressive deafness
in the mouse. This variant predicts a truncated, inactive protein, or no protein at all owing to nonsense-mediated
mRNA decay. It was detected at the homozygous state in the two clinically affected siblings, and at the heterozygous
state in the unaffected parents and one unaffected sibling, whereas it was never found in a control population of 150
Algerians with normal hearing or in the Exome Variant Server database.
Conclusion: Whole-exome sequencing allowed us to identify a new gene responsible for childhood progressive
hearing loss transmitted on the autosomal recessive mode.
Keywords: Epidermal growth factor receptor pathway Substrate 8 L2 (EPS8L2), Progressive deafness, Whole-exome
sequencing, Stereocilia bundleBackground
Deafness is the most common sensory deficit in humans,
with an incidence of 1 in 700 live births. It is estimated that
about two thirds of prelingual severe to profound isolated
(non-syndromic) deafness cases have a genetic cause in de-
veloped countries [1], and autosomal recessive inheritance
(DFNB) accounts for 80 % of the genetic cases [2]. Cases
with autosomal recessive non-syndromic hearing loss
(ARNSHL) are more prevalent in populations where con-
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(http://hereditaryhearingloss.org/). Recessive deafness is
usually prelingual, severe or profound, and fully penetrant,
but some DFNB genes cause progressive hearing loss with
delayed onset in childhood [3, 4].
In Algeria, mutations in GJB2, encoding connexin 26
(Gap Junction Protein Beta 2), account for no less than
35 % of the cases [5–7]. Mutations in other DFNB genes
have also been identified, which illustrates the ARNSHL
genetic heterogeneity in this population [8]. However,
the genetic bases of progressive deafness beginning in
childhood have not been characterized yet. Here, we
report the identification, by whole-exome sequencing
(WES), of a new causal gene for recessively inherited
progressive deafness in an Algerian family.ticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Patients
The two affected siblings were recruited in deafness
schools of Blida and Baraki in Algiers (Algeria), and clinic-
ally examined in the otorhinolaryngology department at
Bab El Oued hospital in Algiers. Medical history and
physical examination of the patients did not reveal any
non-genetic cause for the deafness and confirmed its non-
syndromic nature. Hearing thresholds were determined by
pure tone audiometry between 125 Hz and 8000 Hz, using
air-conduction and bone conduction of sound.Methods
The study was approved by the local Ethics Committee
and the Committee for the Protection of Individuals in
Biochemical Research as required by French legislation. A
written consent for genetic testing was obtained from
every family member. DNA was extracted from peripheral
blood lymphocytes using the Promega Wizard GenomicFig. 1 Clinical and molecular data of the patients harboring a biallelic homoz
segregation of the mutation in the family. The + and – signs denote the wild
are indicated by black symbols. The double horizontal bar joining the parents
curves for patient IV.2 at the ages of 6 (open symbols) and 10 (black symbols)
the hearing thresholds (in dB HL) for the right and left ears are indicated with
showing the mutation (arrow). d Schematic representation of the human EPS
interaction domain (PID), an SRC Homology 3 (SH3) domain, and an effector r
domain of EPS8) including a sterile alpha motif/pointed domain (SAM/PNT)DNA Purification Kit (Promega, Madison, MI, USA, Cat.
# A1120). Whole-exome sequencing and bioinformatic
analysis were carried out as previously described [9]. To
validate the mutation in EPS8L2, sequencing of exon 12
was performed by the Sanger technique with the following
primers: EPS8L2-12 F 5′-GTCTGTGCTGAGGGGAGG-
3′ and EPS8L2-12R 5′-CTCTCCAGAACTGGCCCAC-3′
(http://bioinfo.ut.ee/primer3-0.4.0/primer3/).Results and discussion
We studied an Algerian family with two siblings (IV.1 and
IV.2) presenting with ARNSHI (Fig. 1a). The two affected
children were born to normal hearing second-cousin par-
ents, and reportedly had normal hearing for the first
3 years. The first signs of hearing impairment appeared
around 4 years of age. By 6 years of age, they presented a
bilateral elevation of the hearing threshold, starting at
30 dB at low frequencies (125 Hz) and increasing steadily
up to 90 dB at high frequencies (8000 Hz) (Fig. 1b). At theygous frameshift mutation in EPS8L2. a Pedigree showing the
type and mutant alleles, respectively. The two clinically affected siblings
in generation III indicates consanguinity. b Air-conduction audiometric
years of age. For each pure tone frequency tested (from 0.25 to 8 kHz),
circles and diamonds, respectively. c DNA sequencing chromatograms
8L2 protein. The protein (715 amino acids) contains a phosphotyrosine
egion (46 % of amino acid sequence identity with F-actin binding
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frequencies, ranging from 40 dB at 125 Hz, up to 100 dB
at 8000 Hz (Fig. 1b and data not shown). Of note, audio-
grams showing parallel slopes at 6 and 10 years of age are
rather unusual.
First, we explored the possibility of mutations in GJB2
by Sanger sequencing of the non-coding exon and the
single coding exon of this gene for each patient, and
screened the patients for the common deletion reported
in the promoter region [10]. Since no mutations were
found, we then proceeded to sequence the whole exome
of patient IV.2, and looked for homozygous, compound
heterozygous, or heterozygous variants with a predicted
pathogenicity. None of the genes known to cause
autosomal recessive or autosomal dominant forms of
deafness showed any such variants in coding and
non-coding exons or splice sites. The STRC and OTOA
genes, which were poorly covered by WES, were further
analyzed by single nucleotide polymorphism (SNP) array
and q-PCR. No evidence for genomic rearrangement was
found. Variants with a prevalence superior to 0.01 % in
the DBSNP132, 1000 genomes, HapMap, and Exome Vari-
ant Server databases were excluded. Given the parents'
consanguinity, the causal mutation was searched preferen-
tially among homozygous nonsense, frame-shift, splice
site, and missense variants. From the originally-identified
75,753 SNPs and 5918 insertions/deletions, only 5 SNPs
and 1 deletion (Table 1) appeared as good candidates. The
four missense variants and the synonymous/splice exon
variant were deemed non pathogenic by the prediction al-
gorithms SIFT, PolyPhen2, Mutation Taster and Nnsplice.
In contrast, the homozygous 1-bp deletion c.1014delC
(p.Ser339Alafs*15), located in exon 12 of the EPS8L2 gene,
was predicted to cause a frame shift leading to premature
termination of translation. The causal role of this variant
was further supported by prior work showing that inacti-
vation of this gene in the mouse caused progressive deaf-
ness [11]. After Sanger sequencing of EPS8L2 exon 12 of
the two affected children, the unaffected sister, and the
parents, the segregation analysis confirmed that the muta-
tion was homozygous only in the deaf children, whereas
the parents and the unaffected sibling were heterozygous
for this variant (Fig. 1a, c). Lastly, the variant was never
detected in a control population of 150 Algerians withTable 1 Analysis of Indel and SNP files showing the variants found






TOLLIP NM_019009.3 missensenormal hearing or in the Exome Variant Server database.
We concluded that this frame-shift mutation, predicted to
result either in a truncated inactive protein, or in no pro-
tein at all due to nonsense-mediated mRNA decay, is re-
sponsible for the progressive hearing loss of the two
Algerian patients. EPS8L2 can thus be added to the list
of DFNB genes already reported to cause progressive
ARNSHL in humans: SLC26A4 [12, 13], MYO3A [14],
LOXHD1 [15], PJVK [16–20], SERPINB6 [21], TPRN
[22, 23], TMPRSS3 [24, 25], GIPC3 [26], SYNE4 [27],
GRXCR2 [28], CLIC5 [29], TMC1 [30], GRXCR1 [31],
and LRTOMT [32]. Of note, about 25 % of the DFNB
genes identified so far are responsible for progressive
forms of deafness, and several of them (SLC26A4,
LOXHD1, PJVK, TMPRSS3, GIPC3, TMC1, GRXCR1,
LRTOMT) can cause either non-progressive or pro-
gressive forms of deafness.
EPS8L2 has 24 exons and codes for a 715 amino acid
protein (Fig. 1d), which is a member of the actin-binding
protein EPS8 (epidermal growth factor receptor pathway
substrate 8) family. This family includes four members,
EPS8 and the three EPS8-like proteins (EPS8L1, EPS8L2,
and EPS8L3), with partially overlapping functions [33].
In the mouse ear, EPS8L2 was detected at the stereocilia
tips of both cochlear and vestibular hair cells. Eps8L2
knockout mice undergo progressive hearing loss, as the
result of the progressive disorganization of the hair bun-
dles of both inner and outer hair cells. Scanning electron
microscopy analysis of the hair bundles in the cochlea of
these mice showed that stereocilia of the tall row are
shorter and fewer than those of wild-type mice, whereas
both the middle and small stereocilia rows seem to be
preserved and unaffected [11]. By contrast, mutations in
the EPS8 gene cause profound congenital deafness in
mice and humans [34, 35]. In the mouse cochlea, Eps8 is
essential for the initial elongation of stereocilia [34, 36],
whereas Eps8L2 is required for their maintenance in
mature hair cells [11].
Conclusion
Deafness is a highly heterogeneous disorder, and many
causative genes still remain to be identified. Here, des-
pite several limitations (e.g. only a single family possibly
analysed, uneven exon coverage at certain loci by WES),in the homozygous state in patient IV.2
t Mutation Exon #
c.643G > A; p.Asp215Asn 2
plice c.1848A > G; p.Lys616Lys 11
c.1014delC; p.Ser339Alafs*15 12
c.2138C > T; p.Ala713Val 5
c.631C > G; p.Leu211Val 1
c.481G > A; p.Asp161Asn 4
Dahmani et al. Orphanet Journal of Rare Diseases  (2015) 10:96 Page 4 of 5we were able to identify a new pathogenic variant re-
sponsible for ARNSHL in two Algerian siblings, by com-
bining the powers of WES and genetics. This report is
the first to incriminate EPS8L2, a gene formerly known
to cause deafness in rodents, as a causal gene for pro-
gressive hearing loss in humans.
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